Announcements Trials
Browse Landscape

Status

Completed 174Terminated 68Recruiting 58Active not recruiting 45Unknown 29Withdrawn 17Not yet recruiting 6Enrolling by invitation 4Available 2Suspended 1No longer available 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 18Breast Neoplasms 9Prostatic Neoplasms 8Melanoma 8Colorectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Pancreatic Neoplasms 6Neoplasm Metastasis 6Ovarian Neoplasms 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Glioblastoma 4Carcinoma, Renal Cell 4Stomach Neoplasms 3Solid Tumors 3Multiple Myeloma 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Mesothelioma 2Lymphoma, T-Cell 2Liver Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × INDUSTRY × Urinary Bladder Neoplasms × Clear all
NCT05643690 2024-06-06

Urine Sample Collection for Validation of the AnchorDx UriFindâ„¢ Bladder Cancer Assay

AnchorDx Medical Co. Ltd. US

Suspended
77 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡